Concepedia

Daniele Laszlò

DL

Statistics

Publications

40

Citations

2.2K

H-Index

23

Active since

1994

Affiliations

European Institute of Oncology(Current)

Istituti di Ricovero e Cura a Carattere Scientifico

University of Florence

Azienda Ospedaliero-Universitaria Careggi

University of Siena

Daniele Laszlò is an author at European Institute of Oncology specializing in medicine, hematology, and immunology.

ORCID

Top concepts

Publications per year

1994–2021

40

Publications

40

Clinical Activity of Rituximab in Gastric Marginal Zone Non-Hodgkin's Lymphoma Resistant to or Not Eligible for Anti–<i>Helicobacter Pylori</i> Therapy

Giovanni Martinelli, Daniele Laszlò, Andrés J.M. Ferreri et al. · Journal of Clinical Oncology · 2005 · 267 citations

Addition of Rituximab to Chlorambucil Produces Superior Event-Free Survival in the Treatment of Patients With Extranodal Marginal-Zone B-Cell Lymphoma: 5-Year Analysis of the IELSG-19 Randomized Study

Emanuele Zucca, Annarita Conconi, Daniele Laszlò et al. · Journal of Clinical Oncology · 2013 · 223 citations

Second Allogeneic Bone Marrow Transplantation in Acute Leukemia: Results of a Survey by the European Cooperative Group for Blood and Marrow Transplantation

Alberto Bosi, Daniele Laszlò, Myriam Labopin et al. · Journal of Clinical Oncology · 2001 · 186 citations

A MALT lymphoma prognostic index

Catherine Thiéblemont, Luciano Cascione, Annarita Conconi et al. · Blood · 2017 · 185 citations · Full text

Treatment of refractory chronic GVHD with rituximab: a GITMO study

Francesco Zaja, Andrea Bacigalupo, Francesca Patriarca et al. · Bone Marrow Transplantation · 2007 · 169 citations · Full text

, , +2

1–5 of 40